The TCR:CD3 complex is one of the most important receptors in the immune system. The central theme and long-term objective of this project is to 'determine how TCR:CD3 complexity mediates the multitude of downstream functional events orchestrated by different T cell subsets.' The TCR:CD3 complex is unique in having ten ITAMs, but the physiological significance of this is unclear. In addition to the 23 publications contributed to by this project, we have developed a powerful approach to dissect the contribution of CD3 ITAMs in mediating T cell development and function, which combines retroviral-mediated stem cell gene transfer and 2A peptide-linked multicistronic retroviral vectors. This allowed us to generate 25 groups of 'retrogenic' mice expressing different combinations of wild type and ITAM mutant TCR:CD3 complexes. Our results show that some CD3 mutants cause a lethal, rapidly-developing multiorgan disease. We also found dramatic differences in the TCR signal required for induction of proliferation versus cytokine production. These observations led to the hypothesis that the 'TCR:CD3 complex has the unique ability to provide scalable signaling with a broad dynamic range that can differentially modulate distinct T cell parameters'. In this project, we will use our unique CD3 retrogenic approach, advanced microscopy [time-lapse spinning disk confocal microscopy, with wide-field deconvolution, and total internal reflected fluorescent microscopy (TIRFM) with T cell:APC couples and anti-TCRb/ICAM or MHC class II/ICAM supported lipid bilayers], multiplexed, reverse-phase protein lysate (RPPL) microarrays, and conventional biochemical and functional assays.
AIM 1 : The mechanistic basis for the differential CD3 ITAM requirement for CD4+ T cell proliferation and cytokine production. (A) How does CD3 ITAM number affect IS assembly, kinetics and stability? (B) How does CD3 ITAM number affect the initiation and transmission of TCR signaling? (C) How does CD3 ITAM number affect the mechanism of cytokine production? AIM 2: The relative contribution of CD3 ITAM flavor and location in mediating TCR signaling and T cell function. Our preliminary studies suggest that CD3 ITAM diversity is important as mice expressing CD3 complexes that contain a single ITAM 'flavor' (eg. all ITAMs mutated to the same ITAM sequence) exhibit profound defects in T cell function. (A) What is the consequence of limiting CD3 ITAM diversity on T cell function? (B) What is the consequence of limiting CD3 ITAM diversity on TCR signaling? (C) How important is the location of CD3 ITAMs within the TCR complex in mediating signaling and T cell function? AIM 3: CD3 ITAM requirements for Treg signaling and function. (A) Is Treg function subverted in mice with altered CD3 ITAM number, flavor and/or location? (B) Do alterations in CD3 ITAM number, flavor and/or location have the same effect on IS mechanics and TCR signaling in Tregs?

Public Health Relevance

The T cell receptor (TCR):CD3 complex is one of the most important, complicated and intricate receptor complexes of the immune system, through which almost all immune responses are transmitted. Defects in TCR function can lead to autoimmunity or chronic inflammatory diseases. However, there is still much to be learnt about how TCR signaling is initiated, transmitted, disseminated and regulated. This application will focus on gaining a greater understanding of TCR function which may lead to novel therapeutic interventions.

Agency
National Institute of Health (NIH)
Institute
National Institute of Allergy and Infectious Diseases (NIAID)
Type
High Priority, Short Term Project Award (R56)
Project #
2R56AI052199-06A1
Application #
8112139
Study Section
Cellular and Molecular Immunology - B Study Section (CMIB)
Program Officer
Mallia, Conrad M
Project Start
2002-09-30
Project End
2011-02-07
Budget Start
2010-08-10
Budget End
2011-02-07
Support Year
6
Fiscal Year
2010
Total Cost
$435,000
Indirect Cost
Name
St. Jude Children's Research Hospital
Department
Type
DUNS #
067717892
City
Memphis
State
TN
Country
United States
Zip Code
38105
He, Yanan; Rangarajan, Sneha; Kerzic, Melissa et al. (2015) Identification of the Docking Site for CD3 on the T Cell Receptor ? Chain by Solution NMR. J Biol Chem 290:19796-805
Sakaguchi, Shimon; Vignali, Dario A A; Rudensky, Alexander Y et al. (2013) The plasticity and stability of regulatory T cells. Nat Rev Immunol 13:461-7
Herold, Kevan C; Vignali, Dario A A; Cooke, Anne et al. (2013) Type 1 diabetes: translating mechanistic observations into effective clinical outcomes. Nat Rev Immunol 13:243-56
Collison, Lauren W; Vignali, Dario A A (2011) In vitro Treg suppression assays. Methods Mol Biol 707:21-37
Megas, Charilaos; Hatzivassiliou, Eudoxia G; Yin, Qian et al. (2011) Mutational analysis of TRAF6 reveals a conserved functional role of the RING dimerization interface and a potentially necessary but insufficient role of RING-dependent TRAF6 polyubiquitination towards NF-ýýB activation. Cell Signal 23:772-7
Workman, Creg J; Collison, Lauren W; Bettini, Maria et al. (2011) In vivo Treg suppression assays. Methods Mol Biol 707:119-56
Bettini, Matthew L; Vignali, Dario A A (2010) Development of thymically derived natural regulatory T cells. Ann N Y Acad Sci 1183:1-12
Tseng, Ping-Hui; Matsuzawa, Atsushi; Zhang, Weizhou et al. (2010) Different modes of ubiquitination of the adaptor TRAF3 selectively activate the expression of type I interferons and proinflammatory cytokines. Nat Immunol 11:70-5
Wang, Haopeng; Holst, Jeff; Woo, Seng-Ryong et al. (2010) Tonic ubiquitylation controls T-cell receptor:CD3 complex expression during T-cell development. EMBO J 29:1285-98
Guy, Clifford S; Vignali, Dario A A (2009) Organization of proximal signal initiation at the TCR:CD3 complex. Immunol Rev 232:7-21